Nvwm, LLC Beam Therapeutics Inc. Transaction History

Nvwm, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$29.86 - $62.36 $297,375 - $621,043	-9,959 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$53.73 - $82.16 $5,695 - $8,708	-106 Reduced 1.05%	9,959 $570,000
Q4 2021 Feb 08, 2022	BUY	$68.02 - $99.06 $32,309 - $47,053	475 Added 4.95%	10,065 $802,000
Q3 2021 Nov 03, 2021	BUY	$84.37 - $133.6 $798,140 - $1.26 Million	9,460 Added 7276.92%	9,590 $834,000
Q2 2021 Aug 04, 2021	BUY	$64.12 - $128.71 $8,335 - $16,732	130 New	130 $17,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Nvwm, LLC with notifications on news.